Viewing Study NCT05690035


Ignite Creation Date: 2025-12-24 @ 10:20 PM
Ignite Modification Date: 2026-01-25 @ 12:55 AM
Study NCT ID: NCT05690035
Status: WITHDRAWN
Last Update Posted: 2024-07-09
First Post: 2023-01-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
None mCRC View
Keywords: